Description
Radiochemistry
Adriano Duatti
(International Atomic Energy Agency (IAEA))
19/09/2011, 08:30
Nuclear Chemistry and Radiochemistry
oral presentation
Progress in nuclear medicine has been always closely connected to the availability of a variety of radionuclides having both suitable decay characteristics and chemical properties to allow the development of useful diagnostic and therapeutic agents. Since there’s no ‘universal’ radionuclide capable to cover all clinical needs and imaging applications, nuclear medicine still relies on the...
Boris Zhuikov
(Institute for Nuclear Research of Russian Academy of Sciences)
19/09/2011, 08:50
Nuclear Chemistry and Radiochemistry
oral presentation
Production of isotopes for medical diagnostics and therapy is located in several institutions based on big nuclear facilities all over Russia earlier used for weapon and fundamental research, in particular:
● Research Institute Atomic Reactors (Dimitrovgrad): nuclear reactors, hot cells;
● Karpov Institute of Physical Chemistry (Obninsk branch): nuclear reactor, hot cells;
● Institute for...
Dr
Andrea Salvini
(Università di Pavia)
19/09/2011, 09:10
Nuclear Chemistry and Radiochemistry
oral presentation
The Tc99m is wide used in the world for SPECT diagnostic and its importance is great. In this scenario Italy isn’t different and the lack of production for this isotope suggest to investigate other way to achieve the needs satisfaction. Starting from well known production method by activation, the Laboratory of Nuclear Energy Applied (LENA) of the University of Pavia have developed the method...
Dr
Moumita Maiti
(Saha Institute of Nuclear Physics)
19/09/2011, 09:30
Nuclear Chemistry and Radiochemistry
oral presentation
The mandate of green chemistry is to search newer methods, benign to the environment and Earth, in every sphere of chemical applications. The nuclear and radioanalytical chemistry is no way exception from this mandate. In this paper we present the development of a benign method for separation of 97Ru, a potential candidate radionuclide in the field of nuclear medicine from 12C induced Y target...
Dr
Ondrej Lebeda
(Nuclear Physics Institute AS CR, p.r.i.)
19/09/2011, 09:45
Nuclear Chemistry and Radiochemistry
oral presentation
Cross-section data on proton-induced reactions on natural neodymium are almost entirely missing. The data are of interest for testing predictivity of the nuclear reaction model codes, some of the activation products might have potential in nuclear medicine application, and last, but not least, rate of production of the longer-lived radionuclides is needed for estimating possible disturbing...
Amit Kumar
(Radiochemistry Division, Bhabha Atomic Research Centre)
19/09/2011, 10:00
Nuclear Chemistry and Radiochemistry
oral presentation
Study of reactions involving incomplete mass transfer has been an active area of investigation in heavy ion reactions at low and medium energies. Entrance channel parameters, namely, projectile energy and entrance channel mass asymmetry are important in governing the contribution from different types of reactions involving incomplete mass transfer such as quasi-elastic transfer, massive...
Suparna Sodaye
(Bhabha Atomic Research Centre)
19/09/2011, 10:15
Nuclear Chemistry and Radiochemistry
oral presentation
Fission of heavier actinides and trans-actinides through heavy ion reactions is currently an active area of study to investigate contribution from non compound nucleus fission. In addition, there is a contribution from transfer induced fission. In the present work, mass distributions of the fission products produced in 20Ne + 232Th have been measured at Elab=115 and 145 MeV. Self supporting...
